COMPARATIVE STUDY BETWEEN -BLOCKERS AND COMBINATION OF -BLOCKERS AND PHOSPHODIESTRASE 5- INHIBITORS IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

BLOOD PRESSURE MONITORING STUDY OF THE COMPARATIVE ANTIHYPERTENSIVE FEFICACY OF TWO ANGIOTENSIN II RECEPTOR ANTAGONISTS, IRBESARTAN AND VALSARTAN

Predicting the Outcome of Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia Treated with Alpha Blocker Monotherapy by Measurement of Bladder and Prost

Safety and Efficacy of Silodosin versus Tadalafil in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms; A prospective comparative study

STUDY ON PROTECTION OF CARDIOVASCULAR SYSTEM AND KIDNEY BY DIFFERENT ANGIOTENSIN RECEPTOR BLOCKERS IN EXPERIMENTALLY INDUCED HYPERTENSIVE ADULT MALE ALBINO RATS

Evaluation of Silodosin in Comparison to Tamuslosin in Treatment of Benign Prostatic Hyperplasia with lower Urinary Tract Symptoms: A Prospective Study

Effect of Silodosin versus Tamsulosin in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: Review Article

Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia

EFFECT OF TADALAFIL ADD-ON THERAPY IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA REFRACTORY TO TAMSULOSIN MONOTHERAPY: RANDOMIZED, CONTROLLED

Single Versus Double Dose Tamsulosin for Patients with Moderate or Severe Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: Prospective Randomized Study